Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Real Madrid is behind Barcelona and Bayern Munich in the international match with Germany, but there is no agreement

If there is a team between Bayern Munich, Barcelona and Real Madrid that needs central defenders, it is probably Los Blancos. However, they are behind the other two in the search for Bayer Leverkusen defender Jonathan Tah, who is out of contract in the summer and can sign a pre-contract with any of the three in just over two weeks.

In the summer, it looked like Tah would head to Bayern, despite late interest from Barcelona, ​​but Bayern did not increase their offer from €5 million to the €25 million requested by Leverkusen. All three have courted the 28-year-old, and recent reports in Catalonia have claimed that the Blaugrana have been close to agreeing a deal on Tah’s contract.

Insider Christian Falk confirmed to The Daily Briefing that this is not the case and that Bayern are still in the race for Tah with Barcelona. Real Madrid, for its part, remains interested, but is behind the other two.

Barcelona hope that the presence of Hansi Flick, who managed Tah for Germany, could be decisive in the deal, as Tah would reportedly be willing to accept a lower salary than he would earn elsewhere to join Barcelona. Central defense is not a priority position for the Catalans, but Tah considers an opportunity too good to pass up.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.